The AI in Business Podcast AI’s Impact on the Drug Targeting Process - with Ramesh Durvasula of Lilly
Nov 7, 2023
Ramesh Durvasula, Senior VP of R&D IT at Lilly, discusses AI's impact on drug targeting. AI predicts potential drugs, drives clinical trials as alternative healthcare, and enhances the work of researchers. Generative AI invents new drugs and evaluates chemists' solutions. AI analyzes scientific journals, provides deeper insights, and prompts experimentation for uncertain futures. Caution is advised in enterprise-level AI adoption.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Using Generative AI to Invent New Drugs
02:24 • 7min
The Impact of AI on Researchers in Life Sciences and Healthcare
09:06 • 3min
The Impact of AI on the Drug Targeting Process and the Uncertain Future
12:21 • 4min
Caution and Comparison: AI Adoption in the Enterprise
16:40 • 3min